Investigational study of ustekinumab in the treatment of psoriatic arthritis published
Thursday, February 12, 2009 - 06:42
in Health & Medicine
A group of patients suffering from potentially debilitating psoriatic arthritis showed significant and prolonged improvement after treatment with ustekinumab, according to data from a randomised, double-blind, placebo-controlled study in patients with moderate to severe psoriatic arthritis (PsA). The Phase 2 study was published in the British medical journal The Lancet...